Velan Capital Investment Management LP
Filing Date
Global Rank
#4,705
/ 8,586
▲ 364
Top Industry
Biotechnology
90.8%
3Y Alpha vs SPY
+1.4%
Period ended 3 months ago
Filed May 15, 2026 · 32d
18 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+84.5%
SPY
+78.1%
Annualised alpha
+1.4%
Max drawdown
−54.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
47 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
20.4%
−0.1 pts
Top 5
50.4%
−0.8 pts
Top 10
73.2%
+2.2 pts
HHI
797
Diversified−7
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $159,367,748 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IMMX | Immix Biopharma, Inc. | +705,000 | 740,000 | $6,741,400 | |
| ESPR | Esperion Therapeutics, Inc. | +510,000 | 1,720,000 | $4,712,800 | |
| TENX | Tenax Therapeutics, Inc. | +500,000 | 583,333 | $9,327,494 | |
| CTMX | CytomX Therapeutics, Inc. | +460,000 | 540,000 | $2,538,000 | |
| STRO | Sutro Biopharma, Inc. | +200,160 | 512,160 | $12,757,905 | |
| EDSA | Edesa Biotech, Inc. | +140,000 | 827,500 | $4,327,825 | |
| PMVP | PMV Pharmaceuticals, Inc. | +38,000 | 73,000 | $90,520 | |
| DTIL | Precision Biosciences Inc | +20,000 | 40,000 | $220,000 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | +13,000 | 26,000 | $244,140 | |
| ABVX | Abivax S.A. | +10,000 | 77,000 | $8,573,950 | |
| REPL | Replimune Group, Inc. | +5,000 | 20,000 | $153,000 | |
| VRDN | Viridian Therapeutics, Inc.DE | +4,623 | 91,123 | $1,782,365 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KZIA | Kazia Therapeutics Ltd | −164,685 | 135,315 | $1,006,743 | |
| MLYS | Mineralys Therapeutics, Inc. | −140,000 | 11,000 | $297,990 | |
| SNDX | Syndax Pharmaceuticals Inc | −120,000 | 10,000 | $233,600 | |
| AVTX | Avalo Therapeutics, Inc. | −78,520 | 185,122 | $2,763,871 | |
| EVMN | Evommune, Inc. | −60,499 | 446,255 | $10,259,402 | |
| NSPR | InspireMD, Inc. | −44,046 | 2,099,652 | $3,422,432 | |
| MPLT | MapLight Therapeutics, Inc. | −29,412 | 492,893 | $10,020,514 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AVR | Anteris Technologies Global Corp. | 700,000 | $3,885,000 | |
| XNCR | Xencor Inc | 250,000 | $3,015,000 | |
| LYEL | Lyell Immunopharma, Inc. | 102,000 | $2,046,120 | |
| RCKT | Rocket Pharmaceuticals, Inc. | 294,643 | $1,054,821 | |
| NSRX | Nasus Pharma Ltd | 359,390 | $797,845 | |
| QNRX | Quoin Pharmaceuticals, Ltd. | 84,849 | $560,003 | |
| ARTV | Artiva Biotherapeutics, Inc. | 25,000 | $161,000 | |
| KLRS | Kalaris Therapeutics, Inc. | 18,000 | $103,860 | |
| MGNX | Macrogenics Inc | 30,000 | $86,700 | |
| KPTI | Karyopharm Therapeutics Inc. | 15,000 | $83,550 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LNTH | Lantheus Holdings, Inc. | 74,687 | $4,970,419 | |
| TERN | Terns Pharmaceuticals, Inc. | 70,000 | $2,828,000 | |
| TRVI | Trevi Therapeutics, Inc. | 205,000 | $2,566,600 | |
| XLO | Xilio Therapeutics, Inc. | 170,000 | $1,523,200 | |
| PYXS | Pyxis Oncology, Inc. | 40,000 | $46,000 | |
| No positions match the current search. | ||||
47 positions ·
$159,367,748 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
Held | 70,000 | $23,030 | 0.01% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 45,000 | $72,900 | 0.05% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
NEW | 15,000 | $83,550 | 0.05% | |
| MGNX |
Macrogenics Inc
Healthcare
|
NEW | 30,000 | $86,700 | 0.05% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Added | 73,000 | $90,520 | 0.06% | |
| KLRS |
Kalaris Therapeutics, Inc.
Healthcare
|
NEW | 18,000 | $103,860 | 0.07% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Held | 33,000 | $148,500 | 0.09% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
Added | 20,000 | $153,000 | 0.10% | |
| ARTV |
Artiva Biotherapeutics, Inc.
Healthcare
|
NEW | 25,000 | $161,000 | 0.10% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Held | 20,000 | $212,800 | 0.13% | |
| IMNM |
Immunome Inc.
Healthcare
|
Held | 10,000 | $218,700 | 0.14% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
Added | 40,000 | $220,000 | 0.14% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 10,000 | $233,600 | 0.15% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Added | 26,000 | $244,140 | 0.15% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Held | 16,000 | $248,000 | 0.16% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 100,000 | $262,000 | 0.16% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 11,000 | $297,990 | 0.19% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Held | 160,000 | $355,200 | 0.22% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 3,700 | $389,980 | 0.24% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Held | 6,500 | $407,550 | 0.26% | |
| QNRX |
Quoin Pharmaceuticals, Ltd.
Healthcare
|
NEW | 84,849 | $560,003 | 0.35% | |
| NSRX |
Nasus Pharma Ltd
Healthcare
|
NEW | 359,390 | $797,845 | 0.50% | |
| KZIA |
Kazia Therapeutics Ltd
Healthcare
|
Reduced | 135,315 | $1,006,743 | 0.63% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
NEW | 294,643 | $1,054,821 | 0.66% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Added | 91,123 | $1,782,365 | 1.12% | |
| PROF |
Profound Medical Corp.
Healthcare
|
Held | 285,710 | $1,851,400 | 1.16% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
NEW | 102,000 | $2,046,120 | 1.28% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
Held | 750,000 | $2,287,500 | 1.44% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Held | 2,668,395 | $2,337,513 | 1.47% | |
| VRCA |
Verrica Pharmaceuticals Inc.
Healthcare
|
Held | 471,559 | $2,494,547 | 1.57% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 540,000 | $2,538,000 | 1.59% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Held | 352,000 | $2,548,480 | 1.60% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Reduced | 185,122 | $2,763,871 | 1.73% | |
| XNCR |
Xencor Inc
Healthcare
|
NEW | 250,000 | $3,015,000 | 1.89% | |
| NSPR |
InspireMD, Inc.
Healthcare
|
Reduced | 2,099,652 | $3,422,432 | 2.15% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
NEW | 700,000 | $3,885,000 | 2.44% | |
| EDSA |
Edesa Biotech, Inc.
Healthcare
|
Added | 827,500 | $4,327,825 | 2.72% | |
| ESPR |
Esperion Therapeutics, Inc.
Healthcare
|
Added | 1,720,000 | $4,712,800 | 2.96% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
Added | 740,000 | $6,741,400 | 4.23% | |
| HRTX |
Heron Therapeutics, Inc. /De/
Healthcare
|
Held | 8,753,290 | $7,002,632 | 4.39% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 77,000 | $8,573,950 | 5.38% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Added | 583,333 | $9,327,494 | 5.85% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Reduced | 492,893 | $10,020,514 | 6.29% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Reduced | 446,255 | $10,259,402 | 6.44% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 512,160 | $12,757,905 | 8.01% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
Held | 2,834,652 | $14,768,536 | 9.27% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Held | 100,781 | $32,470,630 | 20.37% |